Results 41 to 50 of about 12,450 (234)

[68Ga]/[188Re] Complexed [CDTMP] Trans-1,2-Cyclohexyldinitrilotetraphosphonic Acid As a Theranostic Agent for Skeletal Metastases

Frontiers in Medicine, 2017
ObjectiveMetastasis of the osseous tissue is one of the frequent and severe aggravations as a result of several neoplastic conditions, such as metabolic disorders, infections, and cancer.
Ambika P. Jaswal, Virendra K. Meena, Surbhi Prakash, Ankita Pandey, Baljinder Singh, Anil K. Mishra, Puja P. Hazari   +6 more
doaj   +1 more source

Installation of First Medium Energy Medical Cyclotron in Bangladesh at National Institute of Nuclear Medicine and Allied Sciences (NINMAS) for PET radiopharmaceuticals Production

Bangladesh Journal of Nuclear Medicine, 2022
PET-CT (positron emission tomography and computed tomography) is a gold-standard cancer imaging tool for diagnosis and management, as well as prognostic information based on treatment. Positron-emitting radionuclide 18F (Fluorine) is generated by accelerating particles to energies high enough to cause a certain nuclear reaction 18O(p,n)18F within the ...
Mohammad Anwar Ul Azim, Sanchoy Chandra Biswasarma, Jashim Uddin, Md Ariful Islam, Nahid Hossain, Md Shohag Mia, Hasan Mehdi, Md Alamgir Kabir, Mustafa Mamun, Ferdoushi Begum, Shamim Momtaz Ferdousi Begum, Md Nurul Islam   +11 more
openaire   +1 more source

Evaluation of imaging protocol for ECT based on CS image reconstruction algorithm

, 2013
SPECT (Single-photon Emission Computerized Tomography) and PET (Positron Emission Tomography) are essential medical imaging tools, for which the sampling angle number, scan time should be chosen carefully to compromise between image quality and the ...
Cao, Xuexiang, Huang, Xianchao, Liu, Shuangquan, Wang, Lu, Wei, Long, Yun, Minkai, Zhou, Xiaolin   +6 more
core   +1 more source

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates

Molecules, 2018
Folic-acid-based radioconjugates have been developed for nuclear imaging of folate receptor (FR)-positive tumors; however, high renal uptake was unfavorable in view of a therapeutic application.
Cristina Müller, Patrycja Guzik, Klaudia Siwowska, Susan Cohrs, Raffaella M. Schmid, Roger Schibli   +5 more
doaj   +1 more source

Radiation exposure from diagnostic nuclear medicine examinations in golestan province [PDF]

, 2013
Introduction: The aim of present study was to estimate effective dose from most common procedures performed in nuclear medicine departments of Golestan province.
Asli, I.N., Assadi, M., Javadi, H., Mogharrabi, M., Parach, A.A., Pashazadeh, A.M., Tabei, F.   +6 more
core  

Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics [PDF]

, 2019
Androgen ablating drugs increase life expectancy in men with metastatic prostate cancer, but resistance inevitably develops. In a majority of these recurrent tumors, the androgen axis is reactivated in the form of increased androgen receptor (AR ...
Beattie, Bradley J., Beattie, Kai A., Elgqvist, Jörgen, Eriksson, Sophie E., Larsson, Erik, Strand, Sven-Erik, Thorek, Daniel L. J., Timmermand, Oskar Vilhelmsson, Tran, Thuy A., Ulmert, David, Örbom, Anders   +10 more
core   +2 more sources

Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito, Chiara Meneghini, Alice Galli, Luca Gallo, Pierfrancesco Mitrotti, Paola Dimartino, Marianna Inglese, Cinzia Zatti, Alessandro Lupini, Andrea Pilotto, Alessandro Padovani, Micol Avenali, Enza Maria Valente, Cristina Tassorelli, Silvia P. Caminiti   +14 more
wiley   +1 more source

Optimization of Reaction Conditions in the Production of Gadolinium Diethylenetriamine Pentaacetate-Folate [PDF]

, 2015
A previous study has performed the laboratory-scale synthesis and characterization of Gadolinium Diethylenetriaminepentaacetate-Folate. Some parameters associated with the synthesis have been defined.
Anggraeni, A., Fauzia, R. P., Gunawan, A. H., Mutalib, A.   +3 more
core  

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Caroline Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative   +19 more
wiley   +1 more source